Navigation Links
KellBenx Secures $2.5 Million Funding Round
Date:4/21/2011

NEW YORK, April 21, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors –  three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.

"We are delighted to have secured this round of funding and the support of our investors," said Hassan Bennani, MD., CEO of KellBenx. "The funds will be used to launch an IRB-approved clinical trial and build our Long Island laboratory to analyze the data we are producing. We are excited about the prospects of our technology and the company going forward."

"We are extremely pleased to partner with such an esteemed group of investors," said Leonard H. Kellner, President of KellBenx. "All of our investors bring tremendous energy, intellect and resources to this partnership, and we plan on leveraging their extensive networks to accelerate the adoption of KellBenx' revolutionary technologies."

About KellBenx

Founded in 2010, KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood.  Our focus is to improve women's healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. For more information, please call 631.643.2614 or visit www.kellbenx.com.


'/>"/>
SOURCE KellBenx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. KellBenx Secures Worldwide Agreement With Cedars-Sinai Medical Center for Biomarker Technology to Predict Premature Births
2. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
3. BioNeutral Group Secures Three Initial Trial Orders for its Ogieneā„¢ Odor Neutralizer & Multi-Purpose Cleaner Product Line
4. ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. SeraCare Life Sciences Secures $20 Million Credit Facilities
7. Medizone International Secures $10,000,000 Funding Commitment
8. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
9. Omeros Secures $40 Million Committed Equity Financing Facility
10. SPO Medical Secures Agreement in Sleep Apnea Market
11. Biolaxy Secures IND Approval for Oral Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 6, 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... fourth quarter and fiscal year ended September 30, 2016. ... , , ... sciences and diagnostics company that develops and commercializes proprietary technologies and ... Achieved revenues of $1.4 million more than tripling prior ...
(Date:12/6/2016)... Collins, Colorado (PRWEB) , ... December 06, 2016 ... ... of dynamic aqueous plasma technology platforms, announced today that the company has engaged ... Master Research and Development Agreement (MRDA) with the CSU Office of the Vice ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International ... $150 million from the National Institutes of Health,s ... the Division of AIDS (NIAID-DAIDS) to support the ... non-vaccine pre-exposure (PreP) agents. Under the seven-year contract, ... product development services for candidate HIV-prevention products that ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
Breaking Biology Technology:
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
Breaking Biology News(10 mins):